MANUFACTURER: Alexion Pharmaceuticals
USAGE: Intravenous
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Pharmaceuticals and Medical Devices Agency (PMDA)
Ultomiris, known by its generic name Ravulizumab, is a medication used to treat two rare and life-threatening blood disorders, namely paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).
